In patients admitted to the hospital with acute heart failure, abnormal glucose tolerance and diabetes are associated with an increased risk of death in the hospital and in the longer term, research indicates.
Read More »Diabetes In Control
Insulin’s Role in Aging and Long Life
New research on insulin shows it plays an important role in aging and lifespan.
Read More »Take the Stairs and Skip the Elevator!
New evidence shows reduced daily physical activity is a direct cause of many risk factors for chronic illnesses like diabetes and cardiovascular disease.
Read More »FDA Approves Abbott’s FreeStyle Navigator® Continuous Glucose Monitoring System
FDA Approves Abbott’s FreeStyle Navigator® Continuous Glucose Monitoring System: New Tool Uniquely Provides Minute-by-Minute and Trend Information That Can Lead to Proactive Diabetes Management.
Read More »Community Pharmacy Practice in the United States and Kenya: Comparision
Do we have it good in America or what? Shejal Parmar PharmD. Candidate, University of Florida, and a recent endocrinology intern spent most of her life in Kenya and she shares her insight into the differences in getting a prescription and what the pharmacist can do for patients.
Read More »1st International Conference On Advanced Technologies And Treatments For Diabetes
The inaugural International Conference on Advanced Technologies and Treatments for Diabetes (ATTD), was held in Prague, Czech Republic, at the end of February and was attended by over 700 registrants from more than 50 countries. Our own, Dr. Ian Blumer was there to get the latest details on the progress …
Read More »Being Underweight Can Raise Diabetes Risk
Being underweight may place men and women over age 60 at increased risk for developing diabetes, researchers report.
Read More »Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
Lilly to Acquire Exclusive Rights to Gastrin/GLP-1 Based Therapies Program for Diabetes.
Read More »Diabetes And Endometrial Cancer Risk
Women with type 2 diabetes had a 70 percent greater likelihood of developing endometrial cancer, study findings suggest.
Read More »Ezetimibe And Twice-Weekly Atorvastatin Effective for Statin-Intolerant Patients
Ezetimibe plus twice-weekly atorvastatin is effective in high-risk patients intolerant to daily statin monotherapy, according to a new report.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.